bluebird bio FDA priority review
-
Den her er ogsaa interessant ifm Novo Nordisk, fordi bluebird og Novo har et haemofili-forskningssamarbejde. Bluebird bio stiger 10% i pre market.
bluebird bio Announces FDA Priority Review of Biologics License Application for beti-cel Gene Therapy for Patients with β-thalassemia Who Require Regular Red Blood Cell Transfusions
https://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-announces-fda-priority-review-biologics-licensebluebird bio and Novo Nordisk Enter into Research Agreement to Develop in vivo Genome Editing Candidates for Haemophilia and Other Severe Genetic Diseases
https://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-and-novo-nordisk-enter-research-agreement-develop
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind